Evidence map›Paper›PMID 34543356›Full record

ArticlePLoS pathogens2021

The HTLV-1 viral oncoproteins Tax and HBZ reprogram the cellular mRNA splicing landscape.

Charlotte Vandermeulen, Tina O'Grady, Jerome Wayet, Bartimee Galvan, Sibusiso Maseko, Majid Cherkaoui, Alice Desbuleux, Georges Coppin, Julien Olivet, Lamya Ben Ameur and 15 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. AProceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. International journal of molecular sciences · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Charlotte VandermeulenLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0001-5026-9567
Tina O'GradyLaboratory of Gene Expression and Cancer, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0002-1283-0293
Jerome WayetUnit of Animal Genomics, GIGA, Université de Liège (ULiège), Liège, Belgium.ORCID 0000-0001-5113-1877
Bartimee GalvanLaboratory of Gene Expression and Cancer, GIGA Institute, University of Liege, Liege, Belgium.
Sibusiso MasekoLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0001-7025-6106
Majid CherkaouiLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.
Alice DesbuleuxLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.
Georges CoppinLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.
Julien OlivetLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0003-4115-5546
Lamya Ben AmeurLaboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, University of Lyon, Lyon, France.ORCID 0000-0002-2975-8822
Keisuke KataokaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0002-8263-9902
Seishi OgawaDepartment of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Olivier HermineService Hématologie Adultes, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Université de Paris, Laboratoire d'onco-hématologie, Institut Necker-Enfants Malades, INSERM U1151, Université de Paris, Paris, France.
Ambroise MarcaisService Hématologie Adultes, Assistance Publique-Hôpitaux de Paris, Hôpital Necker Enfants Malades, Université de Paris, Laboratoire d'onco-hématologie, Institut Necker-Enfants Malades, INSERM U1151, Université de Paris, Paris, France.ORCID 0000-0002-6844-7920
Marc ThiryUnit of Cell and Tissue Biology, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0002-4944-584X
Franck MortreuxLaboratory of Biology and Modeling of the Cell, CNRS UMR 5239, INSERM U1210, University of Lyon, Lyon, France.ORCID 0000-0002-4840-021X
Michael A CalderwoodCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0001-6475-1418
Johan Van WeyenberghLaboratory of Clinical and Epidemiological Virology, Rega Institute for Medical Research, Department of Microbiology, Immunology and Transplantation, Catholic University of Leuven, Leuven, Belgium.ORCID 0000-0003-3234-8426
Jean-Marie PeloponeseUniversité Montpellier, IRIM CNRS UMR 9004 Montpellier, France.ORCID 0000-0002-9677-9703
Benoit CharloteauxCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0003-4282-9688
Anne Van den BroekeUnit of Animal Genomics, GIGA, Université de Liège (ULiège), Liège, Belgium.
David E HillCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.ORCID 0000-0001-5192-0921
Marc VidalCenter for Cancer Systems Biology (CCSB), Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America.
Franck DequiedtLaboratory of Gene Expression and Cancer, GIGA Institute, University of Liege, Liege, Belgium.
Jean-Claude TwizereLaboratory of Viral Interactomes, GIGA Institute, University of Liege, Liege, Belgium.ORCID 0000-0002-8683-705X

Funding

Genomic Analysis of Network Perturbations in Human DiseaseP50HG004233 · NHGRI · DANA-FARBER CANCER INST · PI VIDAL, MARC · 2007 to 2017
$31.6M
Resource ProjectU41HG001715 · NHGRI · DANA-FARBER CANCER INST · PI CALDERWOOD, MICHAEL A, HILL, DAVID E. · 2015 to 2017
$4.7M
NHGRI NIH HHS P50 HG004233NHGRI NIH HHS U41 HG001715
6 · The paper itself

Abstract

Viral infections are known to hijack the transcription and translation of the host cell. However, the extent to which viral proteins coordinate these perturbations remains unclear. Here we used a model system, the human T-cell leukemia virus type 1 (HTLV-1), and systematically analyzed the transcriptome and interactome of key effectors oncoviral proteins Tax and HBZ. We showed that Tax and HBZ target distinct but also common transcription factors. Unexpectedly, we also uncovered a large set of interactions with RNA-binding proteins, including the U2 auxiliary factor large subunit (U2AF2), a key cellular regulator of pre-mRNA splicing. We discovered that Tax and HBZ perturb the splicing landscape by altering cassette exons in opposing manners, with Tax inducing exon inclusion while HBZ induces exon exclusion. Among Tax- and HBZ-dependent splicing changes, we identify events that are also altered in Adult T cell leukemia/lymphoma (ATLL) samples from two independent patient cohorts, and in well-known cancer census genes. Our interactome mapping approach, applicable to other viral oncogenes, has identified spliceosome perturbation as a novel mechanism coordinated by Tax and HBZ to reprogram the transcriptome.

Indexed as

Basic-Leucine Zipper Transcription FactorsGene Products, taxHEK293 CellsHTLV-I InfectionsHumansHuman T-lymphotropic virus 1Jurkat CellsLeukemia-Lymphoma, Adult T-CellRetroviridae ProteinsRNA, MessengerRNA SplicingSplicing Factor U2AFBasic-Leucine Zipper Transcription FactorsGene Products, taxHBZ protein, human T-cell leukemia virus type IRetroviridae ProteinsRNA, MessengerSplicing Factor U2AFtax protein, Human T-lymphotrophic virus 1U2AF2 protein, human

Identifiers

PMID34543356
PMCPMC8483338

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.